Now, Cleveland Clinic researchers may have figured out which patients have the best odds of success. Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight ...

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and ...

Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NASHVILLE -- ...

World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...

A study showing that once-weekly subcutaneous semaglutide 2.4 mg (Wegovy, Novo Nordisk) produces greater long-term weight loss than once-daily injected liraglutide 3.0 mg (Saxenda, Novo Nordisk) among ...

Saxenda is a brand name for the weight loss injectable medicine, Liraglutide. It was approved by the FDA for weight loss nearly a decade ago. Saxenda has been labeled ‘the skinny jab’ and the ‘miracle ...

Carlene Johnson, a 48-year-old Boston resident, couldn’t remember a time when she didn’t feel hungry. Even after eating a full meal, she felt like she needed to eat again just minutes later. She tried ...

The GLP-1 receptor agonist, which was first approved for adults in December 2014, is now a treatment option for adolescents with obesity ages 12-17 as adjunct to diet and exercise. More specifically, ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of liraglutide (Saxenda, Novo Nordisk) for weight loss. The agent, an ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication. It helps with sustained weight loss for adults with obesity, adults with overweight who are experiencing weight-related health issues ...